Claudin-18.2 immunohistochemical evaluation in pancreatic cancer specimens: review and recommendations for routine testing and scoring

The evaluation of claudin-18 (CLDN18) by immunohistochemistry (IHC) has already entered routine diagnostic activity as a predictive biomarker for patients with gastric and gastroesophageal junction adenocarcinomas. Of note, the CLDN18 gene encodes for 2 isoforms, claudin-18.1 (CLDN18.1) and 18.2 (CL...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Luchini, Claudio (VerfasserIn) , Matkowskyj, Kristina A. (VerfasserIn) , Kuwata, Takeshi (VerfasserIn) , Longacre, Teri A. (VerfasserIn) , Schirmacher, Peter (VerfasserIn) , Takamatsu, Manabu (VerfasserIn) , Rüschoff, Josef (VerfasserIn) , Fassan, Matteo (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2025
In: Virchows Archiv
Year: 2025, Jahrgang: 487, Heft: 3, Pages: 487-499
ISSN:1432-2307
DOI:10.1007/s00428-025-04222-2
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s00428-025-04222-2
Volltext
Verfasserangaben:Claudio Luchini, Kristina A. Matkowskyj, Takeshi Kuwata, Teri A. Longacre, Peter Schirmacher, Manabu Takamatsu, Josef Rüschoff, Matteo Fassan

MARC

LEADER 00000naa a2200000 c 4500
001 196154511X
003 DE-627
005 20260218110957.0
007 cr uuu---uuuuu
008 260218s2025 xx |||||o 00| ||eng c
024 7 |a 10.1007/s00428-025-04222-2  |2 doi 
035 |a (DE-627)196154511X 
035 |a (DE-599)KXP196154511X 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Luchini, Claudio  |e VerfasserIn  |0 (DE-588)1390588904  |0 (DE-627)1961545594  |4 aut 
245 1 0 |a Claudin-18.2 immunohistochemical evaluation in pancreatic cancer specimens  |b review and recommendations for routine testing and scoring  |c Claudio Luchini, Kristina A. Matkowskyj, Takeshi Kuwata, Teri A. Longacre, Peter Schirmacher, Manabu Takamatsu, Josef Rüschoff, Matteo Fassan 
264 1 |c 2025 
300 |b Illustrationen 
300 |a 13 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online veröffentlicht: 21. August 2025 
500 |a Gesehen am 18.02.2026 
520 |a The evaluation of claudin-18 (CLDN18) by immunohistochemistry (IHC) has already entered routine diagnostic activity as a predictive biomarker for patients with gastric and gastroesophageal junction adenocarcinomas. Of note, the CLDN18 gene encodes for 2 isoforms, claudin-18.1 (CLDN18.1) and 18.2 (CLD18.2). Recent evidence has shown CLDN18.2 can be expressed in a relatively high rate of cases of pancreatic ductal adenocarcinoma (PDAC). Based on these findings, preclinical research has been conducted, and clinical trials are currently underway testing anti-CLDN18.2 targeted regimens for patients affected by locally advanced unresectable and metastatic PDAC. Notably, the therapeutic strategies with specific antibodies are directed against CLDN18.2, while the antibody for IHC recognizes both isoforms, CLDN18.1 and CLDN18.2. Since CLDN18.1 is not expressed in the stomach or in the pancreas, IHC for CLDN18 in these sites can be considered specific for the isoform CLD18.2. At this time, no specific practical testing or interpretation guidelines have been proposed in this setting. However, there are several preanalytical and analytical variables and key potential pancreas-specific pitfalls, such as the frequently diffuse and strong CLDN18.2 expression in PDAC precursors, which will likely interfere with adequate CLDN18 staining and interpretation. To overcome these issues and steer the standardization of CLDN18 evaluation within the PDAC framework, this manuscript provides practical guidance on CLDN18 testing and scoring. The adoption of a standardized approach will help align all the efforts, both in research and clinical trial settings to optimally guide the most appropriate patients for anti-CLDN18.2 targeted therapies in PDAC. 
650 4 |a CLDN18.2 
650 4 |a Immunohistochemistry, Predictive biomarkers 
650 4 |a Pancreatic cancer 
650 4 |a PDAC 
700 1 |a Matkowskyj, Kristina A.  |e VerfasserIn  |4 aut 
700 1 |a Kuwata, Takeshi  |e VerfasserIn  |4 aut 
700 1 |a Longacre, Teri A.  |e VerfasserIn  |4 aut 
700 1 |a Schirmacher, Peter  |d 1961-  |e VerfasserIn  |0 (DE-588)1020440112  |0 (DE-627)691221197  |0 (DE-576)360427448  |4 aut 
700 1 |a Takamatsu, Manabu  |e VerfasserIn  |4 aut 
700 1 |a Rüschoff, Josef  |e VerfasserIn  |4 aut 
700 1 |a Fassan, Matteo  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Virchows Archiv  |d Berlin : Springer, 1847  |g 487(2025), 3, Seite 487-499  |h Online-Ressource  |w (DE-627)254910645  |w (DE-600)1463276-7  |w (DE-576)074754416  |x 1432-2307  |7 nnas  |a Claudin-18.2 immunohistochemical evaluation in pancreatic cancer specimens review and recommendations for routine testing and scoring 
773 1 8 |g volume:487  |g year:2025  |g number:3  |g pages:487-499  |g extent:13  |a Claudin-18.2 immunohistochemical evaluation in pancreatic cancer specimens review and recommendations for routine testing and scoring 
856 4 0 |u https://doi.org/10.1007/s00428-025-04222-2  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext  |7 0 
951 |a AR 
992 |a 20260218 
993 |a Article 
994 |a 2025 
998 |g 1020440112  |a Schirmacher, Peter  |m 1020440112:Schirmacher, Peter  |d 910000  |d 912000  |e 910000PS1020440112  |e 912000PS1020440112  |k 0/910000/  |k 1/910000/912000/  |p 5 
999 |a KXP-PPN196154511X  |e 4919518730 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"given":"Claudio","role":"aut","family":"Luchini","display":"Luchini, Claudio"},{"family":"Matkowskyj","display":"Matkowskyj, Kristina A.","given":"Kristina A.","role":"aut"},{"display":"Kuwata, Takeshi","family":"Kuwata","role":"aut","given":"Takeshi"},{"given":"Teri A.","role":"aut","family":"Longacre","display":"Longacre, Teri A."},{"display":"Schirmacher, Peter","family":"Schirmacher","role":"aut","given":"Peter"},{"family":"Takamatsu","display":"Takamatsu, Manabu","given":"Manabu","role":"aut"},{"display":"Rüschoff, Josef","family":"Rüschoff","role":"aut","given":"Josef"},{"family":"Fassan","display":"Fassan, Matteo","given":"Matteo","role":"aut"}],"language":["eng"],"note":["Online veröffentlicht: 21. August 2025","Gesehen am 18.02.2026"],"title":[{"title":"Claudin-18.2 immunohistochemical evaluation in pancreatic cancer specimens","title_sort":"Claudin-18.2 immunohistochemical evaluation in pancreatic cancer specimens","subtitle":"review and recommendations for routine testing and scoring"}],"recId":"196154511X","relHost":[{"corporate":[{"display":"European Society of Pathology","role":"isb"}],"id":{"zdb":["1463276-7"],"eki":["254910645"],"issn":["1432-2307"]},"physDesc":[{"extent":"Online-Ressource"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"origin":[{"publisherPlace":"Berlin ; Heidelberg","dateIssuedKey":"1847","publisher":"Springer","dateIssuedDisp":"1847-"}],"language":["eng"],"title":[{"title_sort":"Virchows Archiv","subtitle":"official journal of the European Society of Pathology","title":"Virchows Archiv"}],"note":["Gesehen am 06.12.05"],"recId":"254910645","pubHistory":["1.1847 -"],"titleAlt":[{"title":"Archiv für pathologische Anatomie und Physiologie und für klinische Medicin"},{"title":"Virchows Archiv für pathologische Anatomie und Physiologie und für klinische Medizin"},{"title":"Virchows Archiv / A"}],"part":{"year":"2025","extent":"13","pages":"487-499","volume":"487","text":"487(2025), 3, Seite 487-499","issue":"3"},"disp":"Claudin-18.2 immunohistochemical evaluation in pancreatic cancer specimens review and recommendations for routine testing and scoringVirchows Archiv"}],"origin":[{"dateIssuedDisp":"2025","dateIssuedKey":"2025"}],"name":{"displayForm":["Claudio Luchini, Kristina A. Matkowskyj, Takeshi Kuwata, Teri A. Longacre, Peter Schirmacher, Manabu Takamatsu, Josef Rüschoff, Matteo Fassan"]},"id":{"doi":["10.1007/s00428-025-04222-2"],"eki":["196154511X"]},"physDesc":[{"extent":"13 S.","noteIll":"Illustrationen"}],"type":{"media":"Online-Ressource","bibl":"article-journal"}} 
SRT |a LUCHINICLACLAUDIN1822025